• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肢体软组织恶性纤维组织细胞瘤(未分类多形性肉瘤)治疗后的局部复发。

Local recurrences after the treatment of soft tissue malignant fibrous histiocytoma (unclassified pleomorphic sarcoma) of the limbs.

作者信息

Lytvynenko Oleksandr O, Konovalenko Volodymyr F, Ryzhov Anton Yu.

出版信息

Wiad Lek. 2019 Aug 31;72(8):1523-1526.

PMID:32012503
Abstract

INTRODUCTION

The treatment of patients with malignant fibrous histiocytoma as well as other soft tissue sarcomas is not sufficiently effective up to date, and has largely changed and reflects the alterations, occurred in oncology as a whole. The number of amputation decreased over the last 10-15 years. Some researchers associate the improvement of treatment outcomes with the development of combined and complex methods. The aim of the study is an improvement of the results of treatment of patients with soft tissue malignant histiocytoma on the basis of determination of factors, influencing local recurrence development.

MATERIAL AND METHODS

The basis of our study was a comprehensive analysis of examination and treatment results of 130 patients with MFH of the soft tissue of limbs, of them in 84 patients (64.6%) the recurrences developed. The group included 45 (53.6%) males and 39 (46.4%) females. The major part of patients – 82.1% (60 patients) wereolder than 40 years.

RESULTS AND CONCLUSIONS

Results and conclusions: The number of recurrences after the treatment in general surgical facilities is 86.9%, whereas in the patients after the treatment in the specialized oncological facilities this figure is twice lower (40%). The characteristic of the medical facility where the patient receives his/her primary treatment largely affects the development of local recurrences, patients’ quality of life and overall survival rates. The surgical method remains the leading modality in the treatment of MFH of ST. Wide and radical excision of tumors in the specialized oncological facilities allows achieving better survival outcomes of the patients.

摘要

引言

目前,恶性纤维组织细胞瘤以及其他软组织肉瘤患者的治疗效果仍不够理想,且已发生了很大变化,反映出整个肿瘤学领域的变革。在过去10至15年中,截肢手术的数量有所减少。一些研究人员将治疗效果的改善与联合及综合治疗方法的发展联系起来。本研究的目的是在确定影响局部复发发展的因素的基础上,改善软组织恶性组织细胞瘤患者的治疗效果。

材料与方法

我们的研究基于对130例肢体软组织恶性纤维组织细胞瘤患者的检查和治疗结果进行综合分析,其中84例(64.6%)出现了复发。该组包括45例(53.6%)男性和39例(46.4%)女性。大部分患者(82.1%,即60例)年龄超过40岁。

结果与结论

结果与结论:在普通外科机构接受治疗后的复发率为86.9%,而在专门的肿瘤机构接受治疗的患者中,这一数字低两倍(40%)。患者接受初次治疗的医疗机构的特点在很大程度上影响局部复发的发生、患者的生活质量和总体生存率。手术方法仍然是软组织恶性纤维组织细胞瘤治疗的主要方式。在专门的肿瘤机构广泛彻底切除肿瘤可使患者获得更好的生存结果。

相似文献

1
Local recurrences after the treatment of soft tissue malignant fibrous histiocytoma (unclassified pleomorphic sarcoma) of the limbs.肢体软组织恶性纤维组织细胞瘤(未分类多形性肉瘤)治疗后的局部复发。
Wiad Lek. 2019 Aug 31;72(8):1523-1526.
2
Oral Health and Molecular Aspects of Malignant Fibrous Histiocytoma Patients: A Systematic Review of the Literature.口腔健康与恶性纤维组织细胞瘤患者的分子方面:文献系统评价。
Int J Environ Res Public Health. 2020 Feb 23;17(4):1426. doi: 10.3390/ijerph17041426.
3
Fine-needle aspiration cytopathology of malignant fibrous histiocytoma.恶性纤维组织细胞瘤的细针穿刺细胞病理学
Cancer. 1997 Aug 25;81(4):228-37.
4
[Current topics in the diagnosis and treatment of malignant fibrous histiocytoma].[恶性纤维组织细胞瘤诊断与治疗的当前热点]
Gan To Kagaku Ryoho. 2003 May;30(5):626-33.
5
MFH and high-grade undifferentiated pleomorphic sarcoma-what's in a name?黏液纤维肉瘤与高级别未分化多形性肉瘤——名称中有何深意?
J Surg Oncol. 2015 Feb;111(2):173-7. doi: 10.1002/jso.23787. Epub 2014 Sep 12.
6
Reassessment and clinicopathological prognostic factors of malignant fibrous histiocytoma of soft parts.软组织恶性纤维组织细胞瘤的重新评估及临床病理预后因素
Pathol Int. 2002 Sep;52(9):595-606. doi: 10.1046/j.1440-1827.2002.01399.x.
7
Atypical fibroxanthoma and malignant fibrous histiocytoma.非典型纤维黄色瘤和恶性纤维组织细胞瘤。
J Plast Reconstr Aesthet Surg. 2011 Nov;64(11):e273-8. doi: 10.1016/j.bjps.2011.05.004. Epub 2011 Jun 12.
8
Recurrence of a simultaneous tumor of the parotid gland and scalp skin malignant fibrous histiocytoma.腮腺及头皮皮肤恶性纤维组织细胞瘤同时性肿瘤复发
J Craniofac Surg. 2011 Sep;22(5):1898-999. doi: 10.1097/SCS.0b013e31822ea630.
9
Cross species genomic analysis identifies a mouse model as undifferentiated pleomorphic sarcoma/malignant fibrous histiocytoma.跨物种基因组分析鉴定出一种作为未分化多形性肉瘤/恶性纤维组织细胞瘤的小鼠模型。
PLoS One. 2009 Nov 30;4(11):e8075. doi: 10.1371/journal.pone.0008075.
10
Global protein-expression profiling for reclassification of malignant fibrous histiocytoma.用于恶性纤维组织细胞瘤重新分类的全球蛋白质表达谱分析。
Biochim Biophys Acta. 2015 Jun;1854(6):696-701. doi: 10.1016/j.bbapap.2014.08.012. Epub 2014 Aug 28.